TRAX

First Tracks Biotherapeutics

NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY

$47.78

+14.12% today

Updated 2026-07-30

Market cap

$1.29B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.76

Dividend yield

—

52W range

$11 – $43

Volume

0.8M

Market cap

$1.29B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.76

Dividend yield

—

52W range

$11 – $43

Volume

0.8M

First Tracks Biotherapeutics (TRAX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak

—

Last 8 quarters

Avg EPS surprise

—

Last 4 quarters

Revenue YoY growth

—

Most recent quarter

EPS YoY growth

—

Most recent quarter

When is the next earnings report?

Reporting date

March 31, 2026

Consensus EPS estimate

$-0.55

Fiscal period ending

2026-03-31

Quarterly earnings history

Fiscal quarter ending	EPS estimate	EPS actual	Surprise	Revenue	YoY revenue
2026-03-31	$-0.55	—	—	—	—

Frequently asked questions

When does First Tracks Biotherapeutics report next earnings?

First Tracks Biotherapeutics (TRAX) is scheduled to report earnings on March 31, 2026. The consensus EPS estimate is $-0.55.